Search Results 721-730 of 18384 for Hepatitis C

  1. A Mayo Clinic collaboration studies engineered stem cells for liver disease

    Mayo Clinic is collaborating with industry to develop engineered cells that function like liver cells that could treat alcoholic hepatitis.

  2. Publications - James C. Watson, M.D. - Mayo Clinic

    Watson , James C., Eldrige , Jason, Pagani-Esteves , Gabriel L. Procedural Predictors of Epidural Blood Patch Efficacy in Spontaneous Intracranial Hypotension ...

  3. Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis

    ... hepatitis B, and untreated hepatitis C. Note: A subject who is Hepatitis C antibody positive will be eligible to participate in the study if he/she has ...

  4. A Study to Evaluate the Safety, Tolerability and Metabolism of BIIB105 in Subjects with Amyotrophic Lateral Sclerosis - Mayo Clinic

    - Current hepatitis C infection. - Current hepatitis B infection. - History of alcohol or substance abuse ≤6 months of Screening that would limit

  5. David C. Weber, M.D. - Doctors and Medical Staff - Mayo Clinic

    Education · 1992. ResidentPhysical Medicine and Rehabilitation, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine.

  6. Liver biopsy - Doctors & Departments - Mayo Clinic

    atty liver disease, Cirrhosis, Hepatitis C ... Related. Acute liver failure · Alcoholic hepatitis · Autoimmune hepatitis · Cirrhosis · Enlarged liver · Hepatitis ...

  7. Publications - Brianna C. Leigh, M.D. - Mayo Clinic

    MacQueen BC, Christensen RD, Baer VL, Ward DM, Snow GL. Screening umbilical cord blood for congenital Iron deficiency. Blood Cells Mol Dis.

  8. Publications - Carrie C. Jadlowiec, M.D. - Mayo Clinic

    Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis. World J Gastroenterol. 2021 Mar 28; 27 (12):1240-1254. View PubMed ...

  9. COVID-19: Who's at higher risk of serious symptoms? - Mayo Clinic

    Chronic liver disease, specifically cirrhosis, nonalcoholic fatty liver disease, alcoholic liver disease and autoimmune hepatitis. HIV not well managed with ...

  10. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    Participants seropositive for HBV with undetectable HBV DNA by PCR are permitted with appropriate antiviral prophylaxis. * Negative test results for hepatitis C ...